DNC Statement on Eli Lilly Capping Insulin Costs at $35 a Month
March 1, 2023
In response to the pharmaceutical manufacturer Eli Lilly’s decision to cap the price of its insulin at $35 a month, DNC Chair Jaime Harrison released the following statement:
“Thanks to the leadership of President Joe Biden, Americans across the country will no longer be forced to pay astronomical prices for the life-saving insulin they need. Make no mistake: Eli Lilly’s decision to cap its insulin prices at $35 a month is a direct result of President Biden calling on drug manufacturers to lower insulin prices for everyone else, after Democrats passed the Inflation Reduction Act to cap insulin costs for seniors on Medicare, which every single Republican in Congress voted against. While Democrats fight to bring down costs for American families, MAGA Republicans have threatened to try and repeal the Inflation Reduction Act and raise drug prices for millions of Americans.”